Roche

About

Roche is a pharmaceutical and diagnostics company that focuses on improving people’s lives.

Basel,Basel-Stadt,Switzerland
10001 - max
http://www.roche.com

Highlights

Details

Last Funding Type: Post-IPO Equity
Last Funding Money Raised: $5B
Industries: Biotechnology,Health Care,Health Diagnostics,Pharmaceutical
Founded date: Jan 15, 1896
Number Of Employee: 10001 - max
Operating Status: Active
Stock Symbol: swx:ROG
Legal Name: F. Hoffmann-La Roche Ltd

Roche is a pharmaceutical and diagnostics company that focused on improving people’s lives. Roche is the owner of F. Hoffmann-La Roche Ltd.

Roche is a provider of in-vitro diagnostics and drugs for cancer and transplantation. It specializes in medicines for oncology, virology, inflammation, metabolism, CNS, clinical chemistry, immunology, urinalysis, blood screening, genetics, infectious diseases, and microbiology. F. Hoffmann-La Roche Ltd. serves hospitals, research labs, private medical labs, practicing physicians, and patients.

Its products include cancer treatments, such as Avastin, Herceptin, and MabThera which are also effective in the treatment of rheumatoid arthritis, anemia, and osteoporosis. F. Hoffmann-La Roche Ltd. also conducts research and development as well as production related to molecular diagnostic reagents, test systems, and test kits. In addition, it provides automated instruments, software, consumables, and IT solutions used in in-vitro diagnostics and research.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

5

$7.79B

Roche has raised a total of $7.79B in funding over 2 rounds. Their latest funding was raised on Aug 4, 2021 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Aug 4, 2021	Post-IPO Equity	$5B	1	SoftBank	—	Detail
May 6, 2020	Post-IPO Equity	$500K	1	SCALE AI	—	Detail
Jan 1, 2010	Post-IPO Equity	—	—	—	—	Detail
Mar 14, 2003	IPO	—	—	—	—	Detail
May 8, 2001	Post-IPO Equity	$2.79B	1	Novartis	—	Detail

Investments

Number of Investments

Number of Lead Investments

17

4

Roche has made 17 investments. Their most recent investment was on Dec 8, 2022, when Metagood raised $5M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Dec 8, 2022 Metagood	Pre-seed	$5M	Cryptocurrency	—
Jan 17, 2022 Wilder World	Series Unknown	$30M	3D Technology	—
Jan 11, 2022 Freenome	Corporate Round	$290M	Biotechnology	Yes
Dec 15, 2021 Forethought	Series C	$65M	Artificial Intelligence	—
Nov 16, 2021 Fireside	Seed	$10M	Broadcasting	—

Investors

Number of Lead Investors

Number of Investors

3

Roche is funded by 3 investors. SoftBank and SCALE AI are the most recent investors.

Investor Name	Lead Investor	Funding Round
SoftBank	Yes	Post-IPO Equity
SCALE AI	Yes	Post-IPO Equity
Novartis	Yes	Post-IPO Equity

Employee Profiles

Number of Employee Profiles

119

Roche has 119 current employee profiles, including Executive Severin Schwan

Executive

Executive

Board member

Board member

Executive

Exits

Roche has had 3 exits. Roche most notable exits include C4 Therapeutics , Flatiron Health

Date	Company Name	Exit Type	Industry
Oct 1, 2020	C4 Therapeutics	IPO	Health Diagnostics	Detail
Feb 15, 2018	Flatiron Health	M&A	Biotechnology	Detail
Sep 12, 2014	Affimed	IPO	Biotechnology	Detail

Acquisition

Roche has acquired 51 organizations. Their most recent acquisition was Syntex Corporation on May 3, 1994. They acquired Syntex Corporation for $5.30B.

Date Company Name	Industry	Acquisition Type	Price
May 3, 1994 Syntex Corporation	Health Diagnostics	acquisition	$ 5.30B	Detail
Apr 29, 1995 Roche Biomedical Laboratories Inc.	Biotechnology	acquisition	—	Detail
May 27, 1997 Boehringer Mannheim	Biotechnology	acquisition	$ 11B	Detail
Feb 10, 2003 Disetronic Holding AG	Health Care	acquisition	—	Detail
Jul 19, 2005 Roche Glycart	Biotechnology	acquisition	—	Detail